Generics 3

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Palonosetron manufacturers

3 products found

Filters

Filters

Filters , active

Country of origin : Greece

Clear all

3 products found

palonosetron

Solution for injection 250 mcg/5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Estonia , Latvia , Lithuania
Manufacturer #2346

Manufacturer usually replies in 9 days

palonosetron

Solution for injection 250mcg/5ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam , Greece
Manufacturer #376
A pharmaceutical manufacturer based in the EU that has been active in EU, CIS, Middle East, North America, and Africa selling its products for 40+ years. Key production lines are Rx and OTC. Main therapeutic areas include cardiology, urology, respiratory system, and oncology. The company's production lines are GMP-compliant. Main dosage forms include solids, semi-solid, liquid, and sterile products.

Manufacturer usually replies in 6 days

palonosetron

Solution for injection 250 mg - 5 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Iraq , Vietnam
Available for
Licensing with supply, Technology transfer
Manufacturer #260
Pharmaceutical manufacturer operating in the EU for 50+ years. Activities include scientific development, manufacturing, out-licensing, marketing, and distribution of high-quality generic medicines. The company owns several production facilities that all comply with EU GMP requirements. Key dosage forms include conventional solids, cytostatic injectables, and cytostatic orals. The company holds an in-house R&D and Intellectual property business unit, as well as a regulatory affairs team that prepares CTD dossiers and maintains direct contact with regulatory agencies worldwide. The portfolio includes more than three thousand MA sets approved in the EU while hundreds of MA are in progress. Key therapy lines are cardiovascular, CNS, diabetes, immunology, oncology, and more. The company is active in nearly 100 countries worldwide, selling its products in Africa, Asia, Australia, Europe, LATAM, and the Middle East.

Manufacturer usually replies in 12 days

PALONOSETRON

Palonosetron is a 5-HT3 antagonist, an antinauseant and antiemetic agent. It is used to prevent vomiting and nausea in patients who are on chemotherapy for moderately-emetogenic cancer and for preventing postoperative nausea and vomiting. Palonosetron is specific and selective serotonin 5-HT3 receptor antagonist that is related to other 5-HT3 receptor antagonists, except for structural difference.

Palonosetron is used in intensive care medicine like pneumonia & peritonitis, some diabetes-related foot infections, and as therapy for febrile neutropenia post-chemotherapy. Prolonged infusions can maximize the duration that serum concentration is maintained at a minimum inhibitory concentration of the bacteria causing the infection. As a post-chemotherapy drug, it is given to prevent nausea and vomiting which may occur within 24 hours post-chemotherapy or surgery. It also prevents delayed nausea and vomiting that may occur several days after receiving certain chemotherapies.

Palonosetron is sold under the brand names such as Aloxi Tazocin and Zosyn among others. Helsinn Healthcare SA developed Palonosetron and was approved for this use by the U.S. Food and Drug Administration. It is the most recent 5-HT3 antagonist to enter clinical use and the only drug of its class.

Dosage Forms & Strengths:

Palonosetron is available as an injectable solution in single-use vials of 0.05mg/mL concentrations. For preventing acute Nausea and Vomiting associated with moderately or highly emetogenic chemotherapeutics and for delayed N/V agents, the dose is 0.25 mg, given through IV over 30 seconds, 30 minutes before chemotherapy begins. And for prevention of Postoperative Nausea & Vomiting, the dose is 0.075 mg, administered through an IV infused over 10 seconds immediately before anaesthesia is given.

The price of Palonosetron:

In the USA, the consumers have to pay around $72 for a supply of 2 millilitres of intravenous solution with 0.25 mg of drug in the 2 mL solution. The price for the same supply is significantly cheaper in countries like India, where it costs only USD2.

How does Palonosetron work?

Palonosetron’s actions block serotonin. Serotonin causes vomiting. Palonosetron has a strong binding affinity as 5-HT3 receptor antagonist and little or no affinity for any other receptors. Cancer chemotherapy sees a high incidence of nausea and vomiting, particularly when agents, such as cisplatin, are used.

Finding Palonosetron Manufacturers and Suppliers

The best way to find and gain access to Palonosetron manufacturers and Palonosetron suppliers is to make through Pipelinepharma's global B2B online marketplace for medicines and other pharmaceuticals. Normally, finding trusted manufacturers and supplies of specific drugs like Palonosetron can be a time-consuming challenge, but with Pipelinepharma's simple search engine and network of proven partners, the whole process becomes a lot easier. All you need to do to get started is to make use of our integrated search engine and start looking for suppliers or manufacturers of Palonosetron to work with. You can fine-tune your search results using various filters too, letting you search for Palonosetron from specific countries.